Zobrazeno 1 - 10
of 82
pro vyhledávání: '"D F, Brophy"'
Autor:
D F, Brophy, E J, Martin, J, Christian Barrett, M E, Nolte, J G, Kuhn, P M, Gerk, M E, Carr, H, Pelzer, H, Agersø, M, Ezban, U, Hedner
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 17(5)
Recombinant FVIIa is a haemostatic agent administered to patients with severe FVIII or FIX deficiency with inhibitors. Although rFVIIa is effective at stopping bleeding, a reliable assay to monitor its effect is lacking. To characterize the pharmacok
Autor:
Kumar Villuri B; Department of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia, 23298, United States.; Institute for Structural Biology, Drug Discovery and Development, Virginia Commonwealth University, Richmond, Virginia, 23219, United States., Desai UR; Department of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia, 23298, United States.; Institute for Structural Biology, Drug Discovery and Development, Virginia Commonwealth University, Richmond, Virginia, 23219, United States.
Publikováno v:
Chemistry (Weinheim an der Bergstrasse, Germany) [Chemistry] 2024 Sep 16; Vol. 30 (52), pp. e202402268. Date of Electronic Publication: 2024 Sep 09.
Publikováno v:
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis. 19(6)
To determine the dialysate-to-plasma (D/P) concentration ratios and peritoneal dialytic clearance (CI(D)) of substances with a wide range of molecular weights in subjects receiving a simulated nocturnal intermittent peritoneal dialysis (NIPD) session
Publikováno v:
Pharmacotherapy. 18(3)
Drug therapy in short bowel syndrome can be complicated by inadequate or incomplete absorption of drugs in the small intestine. Many case reports claim that warfarin absorption is not affected by the syndrome. We treated a patient with oral warfarin
Autor:
Du, Yang1,2,3,4,5,6 (AUTHOR), Chen, Yining1,2,3,4,5,6 (AUTHOR), Li, Fangyuan1,2,7 (AUTHOR) lfy@zju.edu.cn, Mao, Zhengwei1,2,8 (AUTHOR) zwmao@zju.edu.cn, Ding, Yuan1,2,3,4,5,6 (AUTHOR) dingyuan@zju.edu.cn, Wang, Weilin1,2,3,4,5,6 (AUTHOR) wam@zju.edu.cn
Publikováno v:
Advanced Science. 11/14/2023, Vol. 10 Issue 32, p1-11. 11p.
Autor:
D. F. Brophy, L. Long
Publikováno v:
Psychological Bulletin. 41:795-802
Autor:
Boothello, Rio S.1 (AUTHOR), Sankaranarayanan, Nehru Viji2,3 (AUTHOR), Sistla, Jyothi C.2,3 (AUTHOR), Nagarajan, Balaji2,3 (AUTHOR), Sharon, Chetna1 (AUTHOR), Chittum, John E.2,3 (AUTHOR), Niyaz, Rabiya Y.1 (AUTHOR), Roy, Swarnali2,3 (AUTHOR), Nandi, Aditi1 (AUTHOR), O'Hara, Connor P.2,3 (AUTHOR), Gangji, Rahaman Navaz3 (AUTHOR), Afosah, Daniel K.2,3 (AUTHOR), Ongolu, Ravikumar2,3 (AUTHOR), Patel, Bhaumik B.1,4,5 (AUTHOR) Bhaumik.Patel@va.gov, Desai, Umesh R.2,3 (AUTHOR) urdesai@vcu.edu
Publikováno v:
Angewandte Chemie. 12/5/2022, Vol. 134 Issue 49, p1-9. 9p.
Autor:
Casey, Sherelle L.1 (AUTHOR) sherelle.casey@gmail.com, Mitchell, Vanessa A.1 (AUTHOR), Sokolaj, Eddy E.1 (AUTHOR), Winters, Bryony L.1 (AUTHOR), Vaughan, Christopher W.1 (AUTHOR) chris.vaughan@sydney.edu.au
Publikováno v:
International Journal of Molecular Sciences. Aug2022, Vol. 23 Issue 15, p8649-8649. 13p.
Autor:
Ren, Jinxuan1 (AUTHOR) 12018551@zju.edu.cn, Lin, Jiaqi1 (AUTHOR), Yu, Lina1 (AUTHOR), Yan, Min1 (AUTHOR) zryanmin@zju.edu.cn
Publikováno v:
International Journal of Molecular Sciences. Aug2022, Vol. 23 Issue 15, p8274-8274. 20p.
Autor:
Stoller F; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Hinds E; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Ionescu T; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Khatamsaz E; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Marston HM; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Hengerer B; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany. bastian.hengerer.ext@boehringer-ingelheim.com.
Publikováno v:
Scientific reports [Sci Rep] 2024 Dec 16; Vol. 14 (1), pp. 30492. Date of Electronic Publication: 2024 Dec 16.